HKD 0.89
(-2.2%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2.15 Billion CNY | -9.42% |
2022 | 2.37 Billion CNY | 13.1% |
2021 | 2.1 Billion CNY | 201.9% |
2020 | 696.95 Million CNY | 115.74% |
2019 | 323.05 Million CNY | 53.81% |
2018 | 210.03 Million CNY | 41.68% |
2017 | 148.24 Million CNY | 53.63% |
2016 | 96.49 Million CNY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 981.82 Million CNY | 0.0% |
2023 FY | 2.15 Billion CNY | -9.42% |
2023 Q2 | 1.14 Billion CNY | 0.0% |
2023 Q4 | 1.01 Billion CNY | 0.0% |
2022 Q2 | 1.1 Billion CNY | 0.0% |
2022 FY | 2.37 Billion CNY | 13.1% |
2022 Q4 | 1.27 Billion CNY | 0.0% |
2021 Q4 | 1.07 Billion CNY | 0.0% |
2021 FY | 2.1 Billion CNY | 201.9% |
2021 Q2 | 1.02 Billion CNY | 0.0% |
2020 Q4 | 499.4 Million CNY | 0.0% |
2020 FY | 696.95 Million CNY | 115.74% |
2020 Q2 | 197.55 Million CNY | 0.0% |
2019 Q4 | 180.71 Million CNY | 0.0% |
2019 Q2 | 142.34 Million CNY | 0.0% |
2019 FY | 323.05 Million CNY | 53.81% |
2018 Q4 | 132.65 Million CNY | 0.0% |
2018 FY | 210.03 Million CNY | 41.68% |
2018 Q2 | 77.38 Million CNY | 0.0% |
2017 Q1 | 37.06 Million CNY | 0.0% |
2017 FY | 148.24 Million CNY | 53.63% |
2017 Q4 | 52.5 Million CNY | 0.0% |
2017 Q2 | 37.06 Million CNY | 0.0% |
2016 Q4 | 37.06 Million CNY | 0.0% |
2016 Q1 | 24.12 Million CNY | 0.0% |
2016 FY | 96.49 Million CNY | 0.0% |
2016 Q2 | 24.12 Million CNY | 0.0% |
2015 Q4 | 24.12 Million CNY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Uni-Bio Science Group Limited | 484.71 Million HKD | -344.708% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.32 Billion HKD | 59.502% |